背景:使用经过验证的问卷评估结果的电子健康工具可能有助于基于测量的精神疾病护理。MoodFX被创建为免费的在线症状跟踪器,以支持患者在抑郁症治疗中进行结果测量。我们进行了一项试点随机评估,以检查其可用性,和临床效用。
方法:出现重度抑郁发作(重度抑郁或双相情感障碍)的患者被随机分配接受MoodFX或健康信息网站作为干预和控制条件,分别,在基线在线进行后续评估调查,8周和6个月。主要可用性结果包括随访期间自我报告使用MoodFX3次或更多次的患者百分比(表明最低限度的使用)和基于系统可用性量表(SUS)的可用性度量。次要临床结果包括抑郁症状快速量表,自测(QIDS-SR)和患者健康问卷(PHQ-9)。
结果:49名参与者被随机分配(24名接受MoodFX,25名接受对照)。在完成用户调查的随机分配给MoodFX的23名参与者中,18(78%)在研究的6个月内使用MoodFX3次或更多次。平均SUS得分为72.7(第65-69百分位数)代表良好的可用性。与对照组相比,MoodFX组在QIDS-SR和PHQ-9评分上有明显更好的改善,在6个月时具有较大的效应大小和较高的应答率。在功能和生活质量等其他次要结局方面,条件之间没有差异。
结论:MoodFX表现出良好的可用性,并与抑郁症状的减轻有关。这项试点研究支持在抑郁症治疗中使用数字工具。
电子健康工具可用于测量和跟踪抑郁症治疗期间的症状和其他结果。这项研究是对MoodFX的随机评估,一个免费的基于网络的应用程序,帮助患者使用经过验证的问卷跟踪他们的症状,并提供抑郁信息和自我管理提示。共有49名患有临床抑郁症的参与者被随机分配到使用MoodFX或健康信息网站。6个月。在一项调查中,使用MoodFX的参与者发现使用起来很容易和有用。此外,使用MoodFX的参与者在6个月后抑郁症状得到了更大的改善,与使用健康信息网站的人相比。这些结果表明,MoodFX可能是监测结果和支持抑郁症治疗的有用工具。
BACKGROUND: e-Health tools using validated questionnaires to assess outcomes may facilitate measurement-based care for psychiatric disorders. MoodFX was created as a free online symptom tracker to support patients for outcome measurement in their depression treatment. We conducted a pilot randomized evaluation to examine its usability, and clinical utility.
METHODS: Patients presenting with a major depressive episode (within a major depressive or bipolar disorder) were randomly assigned to receive either MoodFX or a health information website as the intervention and control condition, respectively, with follow-up assessment surveys conducted online at baseline, 8 weeks and 6 months. The primary usability outcomes included the percentage of patients with self-reported use of MoodFX 3 or more times during follow up (indicating minimally adequate usage) and usability measures based on the System Usability Scale (SUS). Secondary clinical outcomes included the Quick Inventory of Depressive Symptomatology, Self-Rated (QIDS-SR) and Patient Health Questionnaire (PHQ-9).
RESULTS: Forty-nine participants were randomized (24 to MoodFX and 25 to the control condition). Of the 23 participants randomized to MoodFX who completed the user survey, 18 (78%) used MoodFX 3 or more times over the 6 months of the study. The mean SUS score of 72.7 (65th-69th percentile) represents good usability. Compared to the control group, the MoodFX group had significantly better improvement on QIDS-SR and PHQ-9 scores, with large effect sizes and higher response rates at 6 months. There were no differences between conditions on other secondary outcomes such as functioning and quality of life.
CONCLUSIONS: MoodFX demonstrated good usability and was associated with reduction in depressive symptoms. This pilot study supports the use of digital tools in depression treatment.
E-health tools may be useful for measuring and tracking symptoms and other outcomes during treatment for depression. This study is a randomized evaluation of MoodFX, a free web-based app that helps patients track their symptoms using validated questionnaires, and also offers depression information and self-management tips. A total of 49 participants with clinical depression were randomized to using MoodFX or a health information website, for 6 months. In a survey, the participants that used MoodFX found it easy and useful to use. In addition, the participants that used MoodFX had greater improvement in depressive symptoms after 6 months, compared to those who used the health information website. These results suggest that MoodFX may be a useful tool to monitor outcomes and support depression treatment.